Skip to content

Predicting the outcome of a demyelinating event

Predicting the outcome of a demyelinating event - PROUD 2.0

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON56618
Enrollment
450
Registered
2022-07-28
Start date
2022-08-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinically Isolated Syndrome Multiple Sclerosis

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Patient group: 1. Age >=18 years and =18 years and

Exclusion criteria

Exclusion criteria: 1. Severe comorbidity with a life expectancy of 6 months or less at the time of inclusion. 2. Alternative diagnosis as infection or systemic inflammatory disease as etiology of demyelination.

Design outcomes

Primary

MeasureTime frame
To determine the prognostic value of various factors, such as soluble and cellular biomarkers, immunological, genetic, radiological and environmental factors.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)